Pills to swallow at the first symptoms are announced by pharma giants. Who will benefit from it? Four-point lighting.
– —
–
Molnupiravir capsules from Merck. According to the first results communicated by the company, this antiviral reduces by approximately half the risk of hospitalization, if it is taken at the beginning of the disease.
AFP
They have names to sleep outside. But we forgive them, because they bring hope. Two antivirals have just appeared in the fight against Covid.
Pfizer announced on Tuesday that it had requested urgent authorization in the United States for its drug called paxlovid, a treatment administered orally within three days of onset of symptoms.
On November 5, unennew to already caused a sensation: the company revealed that this first antiviral developed specifically against Covid makes it possible to prevent hospitalization or death by 89% in adults with a high risk of developing a serious form of the disease.
–